
Bonviva 3mg/3ml I.V. PF Syringe
Bonviva 3mg/3ml I.V. PF Syringe is a highly effective treatment for postmenopausal osteoporosis, available via PakMeds for professional home delivery.
| Manufacturer | Roche Pharmaceuticals |
| Active Ingredients | Ibandronic Acid |
| Medicine Strength | 3mg/3ml |
| Number Per Pack | 1 Pre-filled Syringe |
| Requires Prescription? | Yes |
| Generics | Bisphosphonates |
Bonviva 3mg/3ml I.V. PF Syringe Ingredients and Usage
Bonviva 3mg/3ml Pre-filled Syringe contains Ibandronic Acid, a potent nitrogen-containing bisphosphonate. This intravenous formulation is specifically indicated for the treatment of osteoporosis in postmenopausal women who are at an increased risk of fractures. It is designed for those who may have difficulty with oral bisphosphonates or require a more direct route of administration. Clinical usage involves a single injection every three months, making it a convenient long-term management option. PakMeds ensures this specialized injectable is delivered under optimal conditions for clinical use.
How Does Bonviva 3mg/3ml I.V. PF Syringe Work?
Bonviva works by targeting the bone remodeling cycle. Ibandronic acid has a high affinity for hydroxyapatite, a part of the mineral matrix of bone. Once administered, the active ingredient incorporates into the bone and inhibits osteoclast activity. Osteoclasts are the cells responsible for bone resorption (breakdown). By reducing the rate of bone turnover, Bonviva leads to a progressive gain in bone mass and an improvement in bone mineralization, significantly reducing the clinical risk of vertebral fractures.
Bonviva 3mg/3ml I.V. PF Syringe Side Effects
Common side effects include flu-like symptoms, such as fever, chills, and muscle or joint pain, particularly after the first dose. Some patients may experience headache, gastrointestinal upset, or pain at the injection site. Rare but serious side effects include osteonecrosis of the jaw and atypical femur fractures.
List of Warnings:
- Only to be administered by a qualified healthcare professional via intravenous injection.
- Contraindicated in patients with severe renal impairment (creatinine clearance below 30 mL/min).
- Patients must have adequate serum calcium levels before starting therapy; treat any hypocalcemia first.
- Regular dental check-ups are recommended to monitor for jaw-related complications.
Bonviva 3mg/3ml I.V. PF Syringe Storage Conditions
Store the Bonviva Pre-filled Syringe at room temperature between 15°C and 30°C. Do not freeze the product. Ensure the syringe remains in its original outer carton to protect it from light. Check for any particulate matter or discoloration before administration.
Reviews
There are no reviews yet.

(0 customer reviews)